ArticleClinical epigenetics2025

Martinostat as a novel HDAC inhibitor to overcome tyrosine kinase inhibitor resistance in chronic myeloid leukemia.

Haeun Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.